These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21540443)

  • 21. Tumour-related factors and prognosis in breast cancer detected by screening.
    Olsson A; Borgquist S; Butt S; Zackrisson S; Landberg G; Manjer J
    Br J Surg; 2012 Jan; 99(1):78-87. PubMed ID: 22068957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
    Domingo L; Salas D; Zubizarreta R; Baré M; Sarriugarte G; Barata T; Ibáñez J; Blanch J; Puig-Vives M; Fernández A; Castells X; Sala M;
    Breast Cancer Res; 2014 Jan; 16(1):R3. PubMed ID: 24410848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.
    Yaghjyan L; Colditz GA; Collins LC; Schnitt SJ; Rosner B; Vachon C; Tamimi RM
    J Natl Cancer Inst; 2011 Aug; 103(15):1179-89. PubMed ID: 21795664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital Compared with Screen-Film Mammography: Measures of Diagnostic Accuracy among Women Screened in the Ontario Breast Screening Program.
    Prummel MV; Muradali D; Shumak R; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ; Chiarelli AM
    Radiology; 2016 Feb; 278(2):365-73. PubMed ID: 26334680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
    Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
    J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
    J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.
    de Roos MA; van der Vegt B; de Vries J; Wesseling J; de Bock GH
    Ann Surg Oncol; 2007 Jul; 14(7):2097-104. PubMed ID: 17453296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme.
    Sala E; Warren R; McCann J; Duffy S; Day N; Luben R
    J Med Screen; 1998; 5(4):207-12. PubMed ID: 9934652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
    Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
    AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
    Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
    Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
    Randall D; Morrell S; Taylor R; Hung WT
    Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.
    Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK
    Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.
    Musolino A; Michiara M; Conti GM; Boggiani D; Zatelli M; Palleschi D; Bella MA; Sgargi P; Di Blasio B; Ardizzoni A
    J Clin Oncol; 2012 Jul; 30(19):2362-8. PubMed ID: 22585698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.